Diabetic peripheral neuropathy

As the most common type of diabetic neuropathy, peripheral neuropathy (PN) is estimated to affect more than 20 million people in the US alone. For patients suffering with this painful condition, treatment options are limited, especially for those seeking alternatives to medication and surgery.

In this webinar, learn how one recent randomized, double-blind, sham-controlled pilot study has identified a promising new treatment - laser therapy. Non-invasive, fast-acting and long-lasting, laser therapy was shown to "significantly reduce pain and improve the overall quality of life of older adults with painful diabetic peripheral neuropathy."

Key Talking Points:

• Review of photobiomodulation mechanisms of action
• Overview of current PN treatment options
• Discussion of new PN study and implications